Form 8-K
Table of Contents

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 1, 2005

 


 

QuadraMed Corporation

(Exact name of registrant as specified in its charter)

 


 

Delaware   0-21031   52-1992861

(State or Other Jurisdiction

of Incorporation)

  (Commission File Number)  

(I.R.S. Employer

Identification No.)

 

12110 Sunset Hills Road, Suite 600, Reston, VA 20190

(Address of principal executive office and zip code)

 

(703) 709-2300

(Registrant’s telephone number, including area code)

 

(Not Applicable)

(Former name or former address, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 



Table of Contents

TABLE OF CONTENTS

 

ITEM 5.02 DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF PRINCIPAL OFFICERS.

 

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.

 

SIGNATURES

 

EXHIBIT INDEX

 

EXHIBIT 99.1


Table of Contents

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers.

 

On February 1, 2005, QuadraMed Corporation (the “Company”) issued a press release announcing that Michael J. King will not seek re-election to the Company’s Board of Directors at the May 10, 2005 Annual Meeting of Stockholders.

 

A copy of this press release is furnished as Exhibit 99.1 to this report and is incorporated by reference in response to this Item 5.02.

 

Item 9.01 Financial Statements and Exhibits.

 

(c) Exhibits

 

Exhibit 99.1 QuadraMed Corporation Press Release, dated February 1, 2005.


Table of Contents

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: February 2, 2005

 

QuadraMed Corporation

/s/ John C. Wright


John C. Wright
Executive Vice President and Chief Financial Officer


Table of Contents

EXHIBIT INDEX

 

Exhibit No.

 

Description


99.1   QuadraMed Corporation Press Release, dated February 1, 2005.